ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 256 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,946,750 | +37.6% | 132,617 | +31.5% | 0.02% | +10.5% |
| Q1 2024 | $2,142,181 | +21.6% | 100,856 | +13.0% | 0.02% | +11.8% |
| Q4 2023 | $1,761,815 | +67.0% | 89,251 | +49.7% | 0.02% | +41.7% |
| Q3 2023 | $1,054,819 | +13.2% | 59,628 | +17.5% | 0.01% | +9.1% |
| Q2 2023 | $932,112 | +77.7% | 50,741 | +82.5% | 0.01% | +83.3% |
| Q1 2023 | $524,567 | +8.1% | 27,799 | +0.1% | 0.01% | 0.0% |
| Q4 2022 | $485,124 | +10.8% | 27,769 | +1.0% | 0.01% | -14.3% |
| Q3 2022 | $438,000 | -20.1% | 27,489 | -13.1% | 0.01% | -12.5% |
| Q2 2022 | $548,000 | +0.9% | 31,639 | +8.1% | 0.01% | +14.3% |
| Q1 2022 | $543,000 | +0.7% | 29,260 | -4.7% | 0.01% | -12.5% |
| Q4 2021 | $539,000 | +20.3% | 30,696 | +15.5% | 0.01% | +14.3% |
| Q3 2021 | $448,000 | -0.4% | 26,569 | +0.2% | 0.01% | -12.5% |
| Q2 2021 | $450,000 | +1.6% | 26,521 | -1.7% | 0.01% | -20.0% |
| Q1 2021 | $443,000 | +71.7% | 26,973 | +91.2% | 0.01% | +66.7% |
| Q4 2020 | $258,000 | – | 14,110 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Wealth Management, LLC | 1,847,358 | $31,128,000 | 4.98% |
| UBP Investment Advisors SA | 714,134 | $12,030,000 | 4.67% |
| swisspartners Ltd. | 305,000 | $5,140,000 | 3.98% |
| Hudock, Inc. | 610,696 | $10,290,000 | 3.10% |
| Newman Dignan & Sheerar, Inc. | 583,831 | $9,838,000 | 2.84% |
| Allen Capital Group, LLC | 605,015 | $10,195,000 | 2.05% |
| American Money Management, LLC | 299,061 | $5,039,000 | 1.42% |
| Cypress Capital, LLC | 574,350 | $9,678,000 | 1.23% |
| COLLECTIVE FAMILY OFFICE LLC | 156,821 | $2,642,000 | 1.14% |
| WOLFF WIESE MAGANA LLC | 93,962 | $1,583,000 | 1.12% |